BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11466355)

  • 21. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
    Rajagopalan G; Smart MK; Cheng S; Krco CJ; Johnson KL; David CS
    Tissue Antigens; 2003 Aug; 62(2):149-61. PubMed ID: 12889995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between superantigens and immunoreceptors.
    Petersson K; Forsberg G; Walse B
    Scand J Immunol; 2004 Apr; 59(4):345-55. PubMed ID: 15049778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
    Rajagopalan G; Smart MK; Krco CJ; David CS
    J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake and intracellular trafficking of superantigens in dendritic cells.
    Ganem MB; De Marzi MC; Fernández-Lynch MJ; Jancic C; Vermeulen M; Geffner J; Mariuzza RA; Fernández MM; Malchiodi EL
    PLoS One; 2013; 8(6):e66244. PubMed ID: 23799083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
    LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
    J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
    Bikoff EK
    J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
    Held W; Waanders GA; MacDonald HR; Acha-Orbea H
    Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
    Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
    Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
    J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of H2-O influence on antigen presentation by B cells.
    Alfonso C; Williams GS; Han JO; Westberg JA; Winqvist O; Karlsson L
    J Immunol; 2003 Sep; 171(5):2331-7. PubMed ID: 12928379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
    Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
    J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
    Nilsson H; Björk P; Dohlsten M; Antonsson P
    J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunodeficiency and autoimmunity in H2-O-deficient mice.
    Gu Y; Jensen PE; Chen X
    J Immunol; 2013 Jan; 190(1):126-37. PubMed ID: 23209323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.